Korea MFDS Revises Regulations for Pharma Clinical Trials
Clinical Trials of Pharmaceuticals |
The Korea Ministry of Food and Drug Safety (MFDS) has revised regulations regarding the approval of clinical trial plans for pharmaceuticals.
This notification will take effect from January 16, 2024.
- Allow the submission of non-animal or human biology-based test (cell-based assays, microphysiological systems, bioprinting, computer modeling, etc.) data for non-clinical trial data.
Comments
Post a Comment